These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7573099)

  • 1. Clinical implications of insulin resistance syndromes.
    Davidson MB
    Am J Med; 1995 Oct; 99(4):420-6. PubMed ID: 7573099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulin resistance syndrome.
    Smolar EN
    Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin resistance: the clinical spectrum.
    Mantzoros CS; Flier JS
    Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin resistance and polycystic ovary syndrome.
    Ehrmann DA
    Curr Diab Rep; 2002 Feb; 2(1):71-6. PubMed ID: 12643125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia of central obesity and insulin resistance.
    Brunzell JD; Hokanson JE
    Diabetes Care; 1999 Apr; 22 Suppl 3():C10-3. PubMed ID: 10189557
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic syndrome X in women].
    Botella Llusiá J
    An R Acad Nac Med (Madr); 2000; 117(2):317-27; discussion 327-30. PubMed ID: 11209548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and sympathetic overactivity in women.
    Kaaja RJ; Pöyhönen-Alho MK
    J Hypertens; 2006 Jan; 24(1):131-41. PubMed ID: 16331111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut hormones, obesity, polycystic ovarian syndrome, malignancy, and lipodystrophy syndromes.
    Bloomgarden ZT
    Diabetes Care; 2007 Jul; 30(7):1934-9. PubMed ID: 17596508
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polycystic ovary syndrome and insulin resistance].
    Puder J; Pralong F
    Rev Med Suisse; 2009 Apr; 5(198):779-82. PubMed ID: 19418980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic syndrome and fatal quartet].
    Standl E
    Internist (Berl); 1996 Jul; 37(7):698-704. PubMed ID: 8766263
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic complications of obesity. Pathophysiologic considerations.
    Sheehan MT; Jensen MD
    Med Clin North Am; 2000 Mar; 84(2):363-85, vi. PubMed ID: 10793647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic complications of polycystic ovary syndrome. Review].
    Velásquez E
    Invest Clin; 2002 Sep; 43(3):205-13. PubMed ID: 12229282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension.
    Montagnani M; Quon MJ
    Diabetes Obes Metab; 2000 Oct; 2(5):285-92. PubMed ID: 11225743
    [No Abstract]   [Full Text] [Related]  

  • 14. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
    Mayer SB; Evans WS; Nestler JE
    Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.
    Barcellos CR; Lage SH; Rocha MP; Hayashida SA; Baracat EC; Romano A; Brito VN; Marcondes JA
    Gynecol Endocrinol; 2013 Apr; 29(4):370-4. PubMed ID: 23327607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistance in polycystic ovary syndrome].
    Aquino Carlos P; Hernández Valencia M
    Ginecol Obstet Mex; 1998 Nov; 66():446-51. PubMed ID: 9823701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.
    Chen MJ; Yang WS; Yang JH; Chen CL; Ho HN; Yang YS
    Hypertension; 2007 Jun; 49(6):1442-7. PubMed ID: 17389259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.